Intrathecal introduction of ginsenoside-Rb1 (Rb1) decreased nociceptive behavior.
Rb1 decreased activation of the proto-oncogene c-Fos in the spinal dorsal horn.
Rb1 inhibited neuronal extracellular signal-regulated kinase phosphorylation.
Rb1 activated the nuclear factor erythroid 2-related factor 2 pathway.
Rb1 inhibited the nuclear factor kappa B pathway.